title: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis.
authors.forename: C N
authors.initials: CN
authors.lastname: Harrison
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: J-J
authors.initials: JJ
authors.lastname: Kiladjian
authors.forename: H K
authors.initials: HK
authors.lastname: Al-Ali
authors.forename: H
authors.initials: H
authors.lastname: Gisslinger
authors.forename: L
authors.initials: L
authors.lastname: Knoops
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.forename: M M
authors.initials: MM
authors.lastname: Jones
authors.forename: K
authors.initials: K
authors.lastname: Sun
authors.forename: M
authors.initials: M
authors.lastname: McQuitty
authors.forename: V
authors.initials: V
authors.lastname: Stalbovskaya
authors.forename: P
authors.initials: P
authors.lastname: Gopalakrishna
authors.forename: T
authors.initials: T
authors.lastname: Barbui